MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
May 21, 2010
Brian Orelli
And You Thought Biotech Was High-Risk, High-Reward Large clinical trials make cardiovascular drugs risky, but the rewards are there, too. mark for My Articles similar articles
BusinessWeek
August 26, 2010
Tom Randall
Cocktails Are Next For Cancer-Drug Makers Taking a cue from the cocktails of drugs that have made AIDS survivable, drugmakers are pursuing combination therapies against cancer. mark for My Articles similar articles
BusinessWeek
January 17, 2005
Otis Port
Holy Screaming Teraflops After more than two years of playing second fiddle to Japan in supercomputers, the U.S. has clawed its way back to the head of the pack. IBM's Blue Gene is the world's fastest supercomputer, for now. mark for My Articles similar articles
The Motley Fool
January 7, 2010
Brian Orelli
Pfizer Strides Farther Into Generics Pfizer's new look might be just what the doctor ordered. mark for My Articles similar articles
InternetNews
May 12, 2004
Susan Kuchinskas
U.S. To Build World's Fastest Computer Tennessee's Oak Ridge National Laboratory wins bid for $50 million grant. mark for My Articles similar articles
The Motley Fool
April 14, 2011
Brian Orelli
Human Genome Sciences Will Be Profitable, Eventually With its first drug on the market -- nearly 20 years after the company was founded -- Human Genome Sciences should start to show meaningful revenue this year. mark for My Articles similar articles
InternetNews
November 14, 2006
Clint Boulton
Spot-Swap Among The World's Fastest Supercomputers IBM's BlueGene/L system is still king of the supercomputing heap, according to the 28th list of the world's 500 most powerful supercomputers. mark for My Articles similar articles
The Motley Fool
March 18, 2004
Brian Gorman
The Drug Cost Conundrum While drug prices continue to climb, the public and its representatives in government are demanding cheaper pharmaceuticals. The industry is not likely to find cover in Medicare biotechnology. Instead, investors should look for drug makers that are finding ways to operate leaner and meaner. mark for My Articles similar articles
The Motley Fool
May 18, 2009
Brian Orelli
Free Drugs! Pfizer's giving over 70 drugs away -- to people who have lost their jobs and health insurance recently and can show financial hardship. mark for My Articles similar articles
The Motley Fool
December 6, 2004
Brian Gorman
Pill-Popping Nation Americans are using more prescription drugs. Unfortunately for big pharma investors, pharmaceutical companies' benefits from these trends are tempered by other factors. mark for My Articles similar articles
The Motley Fool
November 22, 2006
Jack Uldrich
Do the Math: IBM Wins This supercomputer deal is about more than speed. Investors, take note. mark for My Articles similar articles
The Motley Fool
September 30, 2004
Brian Gorman
IBM Claims Computing Crown With BlueGene/L, the world's fastest computer, Big Blue has demonstrated once again that it not only invests in the latest technology, but that its research spending finds its way into practical applications that pay dividends for shareholders. mark for My Articles similar articles
The Motley Fool
November 30, 2010
Brian Orelli
A Witty Response to Pharma's R&D Dilemma According to GlaxoSmithKline CEO Andrew Witty, the pharmaceutical industry is a mess. That's the basic gist of his opinion piece in The Economist. mark for My Articles similar articles
BusinessWeek
September 5, 2005
Putting the FDA Out Front Deputy Commissioner Dr. Janet Woodcock explains how the agency has led the drive for personalized medicine. mark for My Articles similar articles
The Motley Fool
February 22, 2005
Charly Travers
Is Big Pharma a Bargain? While much of the drug sector is looking pretty tasty, Pfizer, with its attractive relative valuation, dominant marketing presence, and willingness to buy up blockbuster drugs, heads the list. mark for My Articles similar articles
The Motley Fool
March 17, 2011
Brian Orelli
Eat or Be Eaten? Perhaps Both. Oft-rumored takeout target Human Genome Sciences goes shopping. mark for My Articles similar articles
Reason
April 2001
Ronald Bailey
Goddamn the Pusher Man Why does everybody seem to hate the pharmaceutical industry? mark for My Articles similar articles
Registered Rep.
March 1, 2005
David A. Twibell
What Ails You? Investors who are wary of big pharma investments have good reasons to be. But this does not mean that the sector is to be avoided at all costs. Indeed, for savvy, well-informed investors, now might be a good time to jump in. mark for My Articles similar articles
PC Magazine
April 20, 2005
Sebastian Rupley
Speed Demon for Rent IBM is offering access to Blue Gene--the speediest of all supercomputers. mark for My Articles similar articles
InternetNews
June 21, 2004
Sean Michael Kerner
Supercomputer Champ Remains (For Now) Japan's NEC still sits atop the annual list of machines with processing powers greater than 1 teraflop, whatever that is. mark for My Articles similar articles
BusinessWeek
June 7, 2004
Port & Tashiro
Supercomputing The race is on. Superfast computers are essential to high-level scientific research. Can the U.S. recapture the lead from Japan? mark for My Articles similar articles